4th Quarter 2022 – The Parenthood Adventures!
In a previous life (ahead of remaining married with youngsters) I was very the traveler.
Quarter
Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2021
• Preliminary translational data validate UCARTCS1 as a promising potential therapy for relapsed orrefractory multiple
Gritstone Reports Second Quarter 2021 Financial Results and Business Update
GRANITE Phase 1/2 data of individualized neoantigen immunotherapy in advanced solid tumors accepted for mini-